Abedelnasser Abulrob

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DGG (talk | contribs) at 02:39, 14 December 2021 (Submitting (AFCH 0.9.1)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

  • Comment: I respect your comments and I found other sources as third party sources for the article. However this article is not WP:ANYBIO since Dr. Abulrob is an academics and scientists. I checked criteria for academics. "Many scientists, researchers, philosophers and other scholars (collectively referred to as "academics" for convenience) are notably influential in the world of ideas without their biographies being the subject of secondary sources." Orajisto (talk) 11:31, 25 January 2021 (EST)
  • Comment: I respect your comments and I found other sources as third party sources for the article. However this article is not WP:ANYBIO since Dr. Abulrob is an academics and scientists. I checked criteria for academics. "Many scientists, researchers, philosophers and other scholars (collectively referred to as "academics" for convenience) are notably influential in the world of ideas without their biographies being the subject of secondary sources." Orajisto (talk) 11:31, 25 January 2021 (EST)
  • Comment: I respect your comments and I found other sources as third party sources for the article. However this article is not WP:ANYBIO since Dr. Abulrob is an academics and scientists. I checked criteria for academics. "Many scientists, researchers, philosophers and other scholars (collectively referred to as "academics" for convenience) are notably influential in the world of ideas without their biographies being the subject of secondary sources." Orajisto (talk) 11:31, 25 January 2021 (EST)
  • Comment: 1.Google Scholar citations are the usual way of showing that someone meets the WP:PROF requirement for influence in one's field
    2.An official university source is enough for awards,
    Inhis case, the highest GS cited artle iscited over 300 times, which is enough for notability DGG ( talk ) 19:18, 13 December 2021 (UTC)
  • Comment: While it is true that academics may be notable per WP:NPROF without meeting WP:ANYBIO, this draft does not show that WP:NPROF is met: there are five sources, three of them are primary, one is a Google Scholar list of search hits which is a very problematic type of source, and the fifth is the Huntington Society reference, which has already been shown to be a trivial mention.
    The "Awards" section is copied verbatim from the author profile in sources 4 and 5. This is problematic not only because it is a potential copyright violation, but also because there is no indication of whether the awards are in fact notable – and for this information, secondary sources are required. bonadea contributions talk 20:09, 14 June 2021 (UTC)
  • Comment: Fails WP:ANYBIO - LinkedIn is not an acceptable source. UOttawa and GOC411 are both primary sources. The Huntington Society reference is a mention in passing. Dan arndt (talk) 01:59, 16 December 2020 (UTC)

  • Comment: I respect your comments and I found other sources as third party sources for the article. However this article is not WP:ANYBIO since Dr. Abulrob is an academics and scientists. I checked criteria for academics. "Many scientists, researchers, philosophers and other scholars (collectively referred to as "academics" for convenience) are notably influential in the world of ideas without their biographies being the subject of secondary sources." Orajisto (talk) 11:31, 25 January 2021 (EST)
Abedelnasser Abulrob
BornAbedelnasser Abulrob
(1965-03-02)March 2, 1965
London, U.K.
Pen name
  • Dr. AbedelNasser Abulrob
EducationUniversity of Jordan (BS)
University of Strathclyde (MSc)
Cardiff University (PhD)

Dr. Abedelnasser Abulrob is a specialist in the areas of cancer therapeutics and personalized medicine.[1] He held several senior level positions at the National Research Council of Canada[2], and is currently an adjunct Professor at the Faculty of Medicine-University of Ottawa in Canada. [3] [4] [5]

Early life

He earned his degree in Pharmaceutical Sciences from the University of Jordan in 1994, a masters in Clinical Pharmacy from University of Strathclyde in Scotland in 1997 and a PhD in Pharmaceutical Cell Biology and Biotechnology at Cardiff University in the UK in 2000[6] [5]

Career

Abulrob joined National Research Council in 2000. He was promoted to be Project Leader & Senior Research Officer in 2006. In 2007 he joined he Department of Cellular & Molecular Medicine, Faculty of Medicine, University of Ottawa as an adjunct Professor[6][7]. According to his website at the University of Ottawa Brain and Mind Institute, he is interested in Molecular Imaging & Personalized Medicine, Biomarker Discovery in Cancer and Brain diseases, Nano-Biotechnology, Therapeutic Drug Delivery & Targeting to the Brain and Drug Pharmacokinetics & Pharmacodynamics"[5]

"

Publications

His most cited journal articles are:

  • Semov A, Moreno MJ, Onichtchenko A, Abulrob A, Ball M, Ekiel I, Pietrzynski G, Stanimirovic D, Alakhov V. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. Journal of Biological Chemistry. 2005 May 27;280(21):20833-41.[2] (Cited210 times, according to Google Scholar [8])
  • Abulrob A, Sprong H, En Henegouwen PV, Stanimirovic D. The blood–brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. Journal of neurochemistry. 2005 Nov;95(4):1201-14. (Cited 215 times, according to Google Scholar. [8])
  • Abulrob A, Giuseppin S, Andrade MF, McDermid A, Moreno M, Stanimirovic D. Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae. Oncogene. 2004 Sep;23(41):6967-79. (Cited 143 times, according to Google Scholar. [8])
  • Abulrob A, Lu Z, Baumann E, Vobornik D, Taylor R, Stanimirovic D, Johnston LJ. Nanoscale imaging of epidermal growth factor receptor clustering: effects of inhibitors. Journal of Biological Chemistry. 2010 Jan 29;285(5):3145-56.(Cited 110 times, according to Google Scholar. [8])

Awards

He received the Industrial Partnership award in 2006, National Research Council Group Achievement award in 2008, National Research Council Entrepreneurship and Innovation Award in 2010, Canada Arab Ambassadors award(science category)in 2013 and NRC Research and Technology Breakthrough Award in 2017.[7]

References

  1. ^ "Investment From The Huntington Society Of Canada And Brain Canada Could Make Gene-Silencing Even More Effective". Huntington Society.{{cite web}}: CS1 maint: url-status (link)
  2. ^ "Seeing is Believing: Molecular Imaging Aids Canadian Biopharmaceutical Sector" (PDF). Pharmaceutical Canada. 9: 14.
  3. ^ "Abedelnasser Abulrob -- Official departmental web page". University of Ottawa.{{cite web}}: CS1 maint: url-status (link)
  4. ^ "Google Scholar". Google Scholar.{{cite web}}: CS1 maint: url-status (link)
  5. ^ a b c "University of Ottawa Brain and Mind Institute". University of Ottawa.{{cite web}}: CS1 maint: url-status (link)
  6. ^ a b "New Technology Detection deadliest brain cancer". Medicine Innovates.{{cite web}}: CS1 maint: url-status (link)
  7. ^ a b "Novel lyp 1 targeted iron oxide nanoparticle early detection triple negative breast cancer". Advances in Engineering.{{cite web}}: CS1 maint: url-status (link)
  8. ^ a b c d [1] Google Scholar Author page, Accessed Dec. 13, 2021

Category:Canadian scientists Category:Living People Category:Academics in Ontario